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A persistent problem in the clinical manage-
ment of primary melanoma is the detection of
cryptic foci of metastatic melanoma. A specific
chemical assay for tyrosinase or for one or more
of the intermediates in the tyrosine-to-mclanin
metabolic pathway would be of value in esti-
mating the degree of dissemination of the tumor.
Such a test would prevent mutilating surgery or
the use of a powerful and potentially injurious
chemotherapeutic agent.
In 1962, Scott (1) reported that dopa can be
identified by paper chromatography as one of the
mclanogens excreted in the urine of patients with
malignant melanoma. The test described below is
a sensitive and reliable means of determining the
amount of dopa present in urine. In this test,
dopa is isolated from interfering substances,
especially catecholamines, by anion and cation
exchange chromatographic columns and spcctro-
fluorophotometric assay. The excellent recovery
of dopa depends upon the surprising stability of
dopa in alkaline borate buffer. The urine of some
patients and mice with malignant melanoma has
been shown by this test to contain increased
amounts of dopa, while the urine of control sub-
jects contained little or none of this substance.
Tyrosinase activity is usually measured by the
respirometer, i.e., by determining oxygen uptake
during the oxidation of tyrosine through dopa to
melanin. This method is not suitable for the
detection of tyrosinasc activity in serum where
the amount of enzyme is small and the oxidation
of dopa to dopa quinonc is inhibited by the many
reducing substances present in serum. The test
to be described here is sensitive enough to detect
very small amounts of dopa formed in an incuba-
tion mixture in which the oxygen uptake is not
significant. In order to increase the sensitivity of
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tyrosinase assay by this method, reducing agents
which augment the accumulation of dopa (ascor-
bic acid and 3-hydroxykynureninc (2)) were
added to the incubation mixture.
Tyrosinasc activity was detected by this
method in 0.1 ml of scram obtained from C-57
black mice with B-16 melanoma (0.5—1.0 gm) and
Swiss albino mice with Harding-Passey melanoma
(1—3 mg); no tyrosinase activity was found in
the serum of control mice.
METHODS
Isolation of Dopa from Urine
The urine tested was obtained from normal
human subjects, patients with malignant
melanoma, and mice with and without melanoma.
The human urine was collected in brown bottles
containing 15—20 ml of 1 N HC1, 5 gm of sodium
bisulfite and 2 gm of boric acid; it was stored at a
temperature of about 5° C in the dark and
analyzed within two days after collection. Each
bottle contained an entire 24-hour specimen. The
24-hour specimens of mouse urine were collected
from groups of 10 Swiss and 12 C-Si mice living
freely in nonmetal metabolism cages. The clear
glass collection bottles, containing small
quantities of the preservatives used with human
urine, were kept at room temperature in dim light
during collection. After collection, the urine was
filtered through glass wool, adjusted in volume to
100 ml with water, and frozen. It was analyzed
within a few days.
For analysis, 2 per cent of each 24-hour specimen
of human urine or 20 per cent of each 24-hour
specimen of mouse urine was diluted with SO—
100 ml of borate buffer, made up to 250 cc with
distilled water (final pH about 8.5), and placed in
each of the borate resin columns used for the
isolation of dopa from urine. Duplicate specimens
were prepared in identical fashion except for the
addition of a known amount of dopa.
For the isolation of dopa from urine, two series
of Dowex resin columns were used. At the begin-
ning of each experiment, 10 ml of Dowex-2-borate
resin was placed in each column (400 mm long;
inner diameter 20 mm) of the first series, making a
layer about 1.6 cm thick; this was covered with
10—20 ml of water to prevent mechanical
disturbance when the urine was added. Enough
Dowex50hydrogen+ resin suspension (about
9.4 ml) was placed in each column (200 mm long;
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inner diameter 10mm) of the second series to make
the layer of resin exactly 6 cm thick. Erlenmeyer
flasks (125 cc) were attached to the top of the
Dowex-50 columns in such a way that they could
receive the eluate from the borate columns and
deliver it to the Dowex-50 columns below. The
dopa fraction passed through the borate columns
by gravity, through the Dowex-50 columns under
a pressure of 3. to jz pound to accelerate flow,
and was collected in suitable flasks.
After the specimens passed through the borate
resin by gravity, each column was washed with
400 ml of 0.5 per cent boric acid solution to remove
catecholamines and other similar amines which
later interfere with the fluorometric assay of
dopa. The borate columns were then placed above
the Erlenmeyer flasks and eluted with 0.2 N
IIC1 (75 cc divided into 2 portions) to release the
dopa. The eluate was collected in the Erlenmeyer
flasks above the Dowcx50hydrogcn+ resin and
passed through this resin under a pressure of3 to J'i pound. The Dowex-50-hydrogen resin
was then washed twice: the first time with 50
ml of 0.2 N HC1, the second time with 100 ml of
water. The dopa fraction was finally eluted from
the Dowex-50-hydrogen resin with 100 ml of
0.5 N HC1, collected in flasks, and used for
spectrofluorophotometry. The Dowex-2-borate
resin was never re-used, but the Dowex-50-
hydrogen+ resin was employed several times after
being regenerated with 100 ml of 8 N IIC1 and
washed with 150 ml of water.
Materials
L-Dopa.—-The stock solution of L-dopa was
prepared by dissolving 10.0 mg of commercial
dopa' in 10 ml of 0.2 N IIC1. This was frozen and
stored in the dark. Immediately before each
experiment, aliquots of this stock solution were
diluted according to need. For recovery, stock
dopa solution was diluted fifty times with water;
4 ml (80 /Lg) of this diluted stock solution were
used. For spectrofluorophotometry, the stock
solution was diluted one thousand times with
0.5 N HCl so that 1 cc contained 1 zg of dopa.
Dowex Resins .—The Dowex-2-borate resin
used in the first series of columns was prepared
from commercial Dowex-2 Cl— (X 8) resin2 by
successive conversion to the acetate form, the
bydroxide form, and finally to the borate form by
washing with saturated boric acid followed by dis-
tilled water. Commercial Dowex-50-W-hydrogen
(X 12) resin2 was prepared for use in the second
series of columns by washing first with 2 N NaOH
solution followed by water, then with 4 N and 8
N IIC1 followed by water. These resins were
stored as 1:1 suspensions in water.
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FIG. 1. Dopa values in 24-hour specimens of
urine from 13 control subjects and 9 patients with
melanoma.
Spectrofluoro photometric Assay of Dopa
This procedure is a modification of the method
described by von Euler and Floding (3) for the
fluorometric estimation of adrenaline and nor-
adrenaline. One milliliter of dopa fraction
obtained from the Dowex-50 resin columns was
shaken with 1 ml of ferricyanide solution for
exactly 2 minutes at room temperature. Oxidation
was then stopped by the addition of 1 ml of
ascorbic acid reagent and 1 minute later the
mixture was put into 3 ml quartz curvettes and
read in the spectrofluorophotometer, using
370 mp as the wavelength of excitation and 480
rn/h as the wavelength of emission at slit arrange-
ment No. 3 on the apparatus used. The standard
curve run with every assay was prepared from the
1,000 times diluted stock solution of dopa, which
contained 1 pg of dopa/ml, by putting 0, 0.2, 0.4,
0.6, 0.8 and 1.0 pg in successive test tubes and
adding 0.5 a IIC1 to make 1 ml. When the resin has
been well prepared, it should not show much
more fluorescence than is found in the blank
obtained from 0.5 N HCI; if it does contain more,
the fluorescence value of the blank should
subtracted from the fluorescence value of the
sample. If the recovery is less than 60 per cent the
assay should be discarded.
'Manufactured by Aminco-Keirs Co., Silver
Spring, Maryland.
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'Prepared by Hoffmann-LaRoche Company,
Easel, Switzerland.
2 Manufactured by Dow Chemical Company,
Midland, Michigan (200—400 mesh).
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with malignant melanoma are shown in Fig. 1. All
the urine obtained from patients with melanoma
gave higher dopa values than the urine from con-
trol subjects even though there was no noticeable
melanuria. The dopa values of urine from Swiss
mice, tumor development and time of tumor
excision are shown in Fig. 2. A few dopa values
have also been obtained from the urine of C-57
black mice (12 control; 12 with B-16 melanoma).
No tyrosinase activity was found in the pooled
serum of healthy C-57 black mice, but 0.5 ml of
of pooled serum from C-57 mice with B-16 mel-
anoma (1—3 gm) converted 181 g of tyrosine into
24 ig of dopa during incubation for 6 hours at
37° C. Fig. 3 shows the rate of dopa accumulation
during incubation at 37° C for 6 hours, in 0.1 ml
of pooled serum from a group of 30 C-57 black
mice with very large, advanced B-16 melanoma.
The method of tyrosinase assay described
here is sensitive enough to detect the tyrosinase
activity present in 0.1 ml of pooled serum from
from melanoma-bearing mice. It is hoped that the
test can be made more sensitive than this. No
tyrosinase activity was detected by this technic
in 2 ml-samples of serum obtained from 2 patients
with melanoma.
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FIG. 2. Dopa values in 24-hour specimens of
pooled urine from three groups of 10 Swiss
mice with Harding-Passey melanoma. BT =
before tumor transplantation. 1 M = 1 month
after tumor transplantation. 2 M = 2 months
after tumor transplantation. AE = after excision
of tumor.
The following reagents were used in this assay.
They were always freshly prepared.
Fern cyanide solution
25 mg potassium fern cyanide
1 gm NaOH
50 ml 1 M sodium acetate buffer, pH 6.0
Ascorbic acid reagent
1 ml 2% ascorbic acid solution
9 ml 20% NaOH solution
Assay of Tyrosinase in Serum
In these experiments, incubation was carried
out in a medium composed of 181 jg of L-tyrosine,
448 g of D, L-3-hydroxykynurenine, and 2 mg of
ascorbic acid in 2 ml of 0.05 M phosphate buffer
at pH 6.8. Between 0.1 and 0.5 ml of serum
obtained from mice with and without melanoma
was incubated in 2 ml of this medium for 4—6
hours at 37° under aerobic conditions. Incubation
was stopped by adding 2 ml of absolute alcohol.
The mixture was diluted with 80—100 ml of borate
buffer and enough water to make 250 cc, as
described, and put in the column.
RESULTs
The dopa values obtained from the urine of
13 normal, healthy, human subjects and 9 patients
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FIG. 3. Accumulation in a special medium of
the dopa formed during incubation at 37° C from
the tyrosinase present in 0.1 ml of serum from
C-57 black mice with and without B-16 melanoma.
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Fin. 4. Recovery of catecholamines from a borate resin column by repeated elution with 0.5 per cent
boric acid solution (400 cc used in 8 parts) which did not release dopa from the resin. Release of dopa
with 0.2 N HC1. Filt. = filtrate. B-i = first elution. B-2 = second elution. B-3 = third elution, etc.
HC1-1 = first elution (50 cc). HCI-2 = second elution (50 cc).
DISCUSSION
Within the range of pH 7.0—9.0 there is a
striking difference between the stability of dopa
in phosphate buffer and its stability in borate
buffer. When dopa was added to phosphate buffer
at pH 8.6, a red color began to develop quickly
and became dark after S hours; a black precipitate
was found at the bottom of the solution after
several days. By contrast, when dopa was put
into borate buffer at the same pH, no noticeable
color developed within 5 hours and the solution
became only slightly brown after standing for
several days at room temperature. Most of the
dopa could be recovered from this slightly brown
solution. In using the procedures now available
for the isolation of catecholamine derivatives by
means of alumina columns it is essential to bring
the pH of the samples to the alkaline side by
very careful neutralization, using a pH meter,
even though some of the ortho-dihydroxy deriva-
tives may be oxidized within a short time, thus
making recovery poor. The advantage of the
Dowex-2-boratc resin over the Cl— and acetatc
resins is that it not only protects the dopa against
oxidation, but that it also has more holding-
capacity because the borate ion is easily released
from the resin. As is shown in Fig. 4, all the
catecholamines tested were eluted from a borate
column with 400 ml of 0.5 per cent boric
acid solution which did not release dopa from the
borate resin. With this technic, the final dopa
fraction was found to be colorless and to con-
tam no salt after passing through the two resin
columns in sequence.
The effect of L-tyrosine,4 3-methoxytyrosine,5
3-methoxytyramine,5 and normethanephrine5 on
the fluorometric assay of dopa has been tested;
none of these substances appreciably altered
dopa recovery. When added to the incubation
mixture, synthetic D-L-3-hydroxykynurenine4
and synthetic xanthommatin° had no effect on
the fluorescence of dopa. This indicates that in
this method, the xanthommatin which forms in
the incubation mixture in the presence of tyro-
sinase (2) does not affect the fluorescence read-
ing.
Dr. Lot B. Page of the Department of Medi-
cine, Massachusetts General Hospital, reports
(5) that with the technic described here he has
found a daily dopa excretion of 400 to 900 jigm in
the urine of a patient with neuroblastoma and
none in control subjects.
SUMMARY
A reliable and sensitive method of isolating
dopa from urine has been described. This method
is based on the striking stability of dopa in
borate buffer. Much more dopa was found in the
Purchased from Mann Research Laboratories,
New York, N. Y.
Supplied by Dr. Lot B. Page, Department of
Medicine, Massachusetts General Hospital, Bos-
ton 14, Massachusetts.
6 Synthesized by H. Takahashi from D-L-3-hydroxykynurenine4 by the method of Butenandt
et el (4).
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urine of both patients and mice with melanoma
than in the urine of normal control subjects and
normal mice. The tyrosinasc activity contained in
a small amount of the serum of mice with mel-
anoma was detected by measuring the dopa which
accumulated in a special tyrosine-scrum incuba-
tion mixture.
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